Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

RemSleep Holdings (RMSL) Research & Development (2022 - 2025)

RemSleep Holdings' Research & Development history spans 5 years, with the latest figure at $1500.0 for Q2 2025.

  • For Q2 2025, Research & Development fell 98.88% year-over-year to $1500.0; the TTM value through Sep 2025 reached $9350.0, down 97.67%, while the annual FY2024 figure was $187445.0, 36.42% down from the prior year.
  • Research & Development for Q2 2025 was $1500.0 at RemSleep Holdings, down from $17200.0 in the prior quarter.
  • Across five years, Research & Development topped out at $205220.0 in Q4 2023 and bottomed at -$9350.0 in Q4 2024.
  • The 4-year median for Research & Development is $32416.5 (2022), against an average of $59856.9.
  • The largest YoY upside for Research & Development was 193.62% in 2024 against a maximum downside of 104.56% in 2024.
  • A 4-year view of Research & Development shows it stood at $152145.0 in 2022, then surged by 34.88% to $205220.0 in 2023, then plummeted by 104.56% to -$9350.0 in 2024, then surged by 116.04% to $1500.0 in 2025.
  • Per Business Quant, the three most recent readings for RMSL's Research & Development are $1500.0 (Q2 2025), $17200.0 (Q1 2025), and -$9350.0 (Q4 2024).